| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  1928 Diagnostics Where complex data turns into actionable results. 1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems. bioinformatics, software, antibiotic resistance, infection diagnostics, microbiology, MRSA, next generation sequencing, whole genome sequencing, outbreak surveillance, software-as-a-service, clinical bacteriology, molecular biology, and genomics Type: | 1 | 1 | 0 | 13 |
 | 23andMe 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers … Type: | 20 | 3 | 4 | 888 |
 | 3Bar Bio Activating the Power of Microbes 3Bar Biologics is a cutting-edge biotech company that helps the agricultural value chain optimize their solutions for improving quantity and quality of crop production. 3Bar’s proprietary delivery method grows fresh microbes on-site to ensure farmers have the most viable and abundant beneficial microbes at the time of application. By partnering with innovative like-minded companies and research universities, 3Bar is delivering the highest quality and most cost-effective biological microbe solutions to drive profitability for the agriculture industry, while also reducing its dependence on synthetic chemicals. Manufacturing, Innovative Packaging, Engineering, and Supply Chain Type: | 0 | 0 | 0 | 26 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 4 |
 |  3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 0 | 0 | 0 | 53 |
 | 3B ́s Research Group The 3B’s Research Group (Biomaterials, Biodegradables and Biomimetics) was established in 1998 at the University of Minho and supports a multidisciplinary and highly skilled team which works at the interface of biotechnology, biology, biomedical engineering and materials science. Major research areas at our group include, among others, new materials development, drug delivery, tissue engineering, regenerative medicine, nanomedicine, and stem cell isolation and differentiation. The group belongs to the Associate Laboratory IBB – Institute for Biotechnology and Bioengineering that has branches in several locations in Portugal. It also leads the European Institute of Excellence on Tissue Engineering and Regenerative Medicine that … Type: | 0 | 0 | 0 | 103 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an abitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 13 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 2 | 0 | 1 | 230 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 1 | 1 | 0 | 12 |
 | 4mg TRANSPARENCY [Automatic translation follows] Manage your core business, we manage its Transparency! Manage your core business, we manage its Transparency! 4mgTRANSPARENCY works with the Health Industry (pharmaceuticals, medical devices, medical visit providers, medical information delegates, Health events, PSAD) and Health Professionals by offering a personalized management solution, internal or outsourced, of regulatory functions and LEA (ex DMOS) from A to Z thanks to comprehensive support on the subject: - Audit of internal LEA management processes (ex DMOS) and Transparency - Management of administrative files (IDAHE, EPS) - Implementation of 4TRANSPARENCY, the innovative, efficient, profitable and agile digital platform that simplifies Transparency … Type: | 39 | 0 | 39 | 4 |
 | 4Moving Biotech Restoring mobility for a better quality of life 4Moving Biotech is a clinical-stage biopharmaceutical company founded in 2020. We are committed to develop first-in-class breakthrough therapies for the millions of patients suffering from osteoarthritis (OA) in the world. 4Moving Biotech is a subsidiary of 4P-Pharma, an innovation accelerator biotech company. Osteoarthritis, DMOAD, Research and Development, and Biotechnology | 4 | 3 | 0 | 7 |
 | 4P-Pharma Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and … Type: | 6 | 2 | 4 | 30 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: | 1 | 1 | 0 | 20 |
 |  9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture Type: | 0 | 0 | 0 | 2 |
 | A-Alpha Bio The protein-protein interaction company A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of … Type: | 4 | 0 | 4 | 53 |
 | AARDEX Group - Medication Adherence Tools Prescribing the Future of Medication Adherence Management 💊 At AARDEX Group, we believe in the power of digital solutions to revolutionize the way we measure and manage medication adherence. We're not just talking the talk; we're walking the walk as the world leader in this space. Our cutting-edge technology, MEMS® Adherence Software (MEMS AS®), is the cornerstone of a comprehensive ecosystem designed to deliver accurate, data-driven adherence analytics across all forms of drug administration. But we don't stop there. Our team is dedicated to continuously innovating and pushing the boundaries of what's possible in the world of clinical trials. Our … Type: | 4 | 2 | 2 | 31 |
 | AATec Medical Unlocking the therapeutic potential of AAT AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections. Type: | 0 | 0 | 0 | 7 |
 | Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: | 8 | 4 | 6 | 47 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 10 |
 | AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: | 9 | 1 | 2 | 551 |
 | AberActives SAS [Automatic translation follows] Biorefining marine algae for nutraceuticals and cosmetics AberActives is a marine biotechnology company Our laboratory is located on the Laber site in the premises of the Roscoff marine station, a global center of excellence in fundamental research on algae. The start-up offers the use of bacterial enzymes to transform algal sugars with a view to manufacturing ingredients in cosmetics and/or health nutrition. Type: | 3 | 3 | 0 | 6 |
 | Abingdon Health plc Improving life by making rapid results accessible to all. Lateral flow test development, manufacture & commercialisation We are lateral flow CDMO experts based in the UK supporting global customers bring their assays to market, from proof of concept, through optimisation and scale up to routine manufacture, along with full-service regulatory consultancy support. Get in touch: email info@abingdonhealth.com today. We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the … Type: | 5 | 0 | 3 | 73 |
 | ABIONYX Pharma A New Generation Biotech Company ABIONYX Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. | 2 | 1 | 1 | 7 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 8 | 5 | 4 | 78 |
 | ABL GMP PURE-PLAY VIRAL VECTOR CDMO. From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< … Type: | 5 | 5 | 2 | 515 |
 | ABL Diagnostics S.A [Automatic translation follows] Improving Disease Management Founded in 2015, ABL DIAGNOSTICS designs, develops, manufactures, markets and supports in France and internationally, directly or via a network of exclusive distributors in 45 countries, molecular biology diagnostic tests for detection (UltraGene®) and genotyping by DNA sequencing (DeepChek®), for infectious diseases. These are the result of proprietary know-how acquired over the years and scientific collaborations with renowned teams and dedicated technical protocols. ABL DIAGNOSTICS has particularly developed high-tech genotyping medical devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and also for the genotyping of SARS-CoV-2 (Covid-19), as well as other … Type: | 1 | 1 | 0 | 21 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 15 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make … Type: | 11 | 1 | 11 | 42 |
 | Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: | 7 | 0 | 8 | 184 |
 | AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … Type: | 2 | 1 | 0 | 104 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: | 2 | 2 | 0 | 2 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 446 |
 | ACAVI - Talent Acquisition Partner Management des Ressources Humaines ACAVI est une société spécialisée en Executive Search et Recrutement, Assessment spécialisé et Conseil stratégique et opérationnel dédié au Top et Middle Management des entreprises et structures académiques du secteur des Sciences de la Vie, la Chimie et les Matériaux. ACAVI est positionné en France et dans le monde comme Leader expert des métiers à forte valeur ajoutée de la Recherche, Développement, Industrialisation, Réglementaire, Qualité, Commercial, Marketing et Service. ACAVI is a company specialized in Executive Search and Recruitment, Assessment and Strategic and Operational Consulting dedicated to the Top and Middle Management for companies and academic … | 0 | 0 | 0 | 16 |
 | Accelerated Cure Project for Multiple Sclerosis We work in collaboration to improve the health, healthcare, and quality-of-life for people affected by MS. The Accelerated Cure Project for Multiple Sclerosis (ACP) is a non-profit organization whose mission is to accelerate research efforts to improve diagnosis, optimize treatment, and to cure Multiple Sclerosis (MS). ACP believes that research is the only way to greatly improve the outlook for people with MS. The organization promotes scientific collaboration and accelerates research by rapidly and cost-effectively providing researchers with data and biospecimens they need to explore novel research ideas that can lead to better care for people with MS. Its strategic … Type: | 0 | 0 | 0 | 19 |
 | Acceleron Pharma Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Type: | 4 | 1 | 2 | 75 |
 | Accelrys Accelrys was founded in 2001 from the combination of five companies: Molecular Simulations Inc, Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd. In 2004, Accelrys acquired SciTegic, the developer of Pipeline Pilot data pipelining and scientific workflow authoring software. In July 2010, Accelrys merged with Symyx Technologies, Inc., combining the Accelrys portfolio of scientific informatics solutions with the market-leading Symyx electronic laboratory notebook (ELN). The Accelrys-Symyx merger also extended Accelrys’ product offerings with certain software and content products from MDL Information Systems, Inc., which Symyx had acquired from Elsevier, Inc. in 2007. MDL had been … Type: | 1 | 1 | 1 | 7 |
 | Access to Medicine Foundation Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and … Type: | 6 | 3 | 3 | 52 |
 | Accrete AI Unleash Your Genius Accrete AI delivers universally configurable, reliable, and accurate analytical AI agents that perform work that would otherwise require teams of experts and generate insights beyond human capacity. Our vision is to create a path to ethical, reliable, and trustworthy artificial general intelligence by deploying analytical AI agents across every domain that capture and scale tacit domain knowledge and create net new knowledge reasoned from ground truth. Our mission is to enable our customers to grow in previously unimaginable ways. Artificial Intelligence, Supply Chain Risk Management, OSINT, Unstructured Data, Social Media Intelligence, Continuous Learning, Explainable AI, Knowledge Graph, … Type: | 1 | 0 | 1 | 151 |
 | AccuHealth Chile [Automatic translation follows] Together in control of your health We are the first Telehealth company in Chile and South America. Our Virtual Clinical Hospital is dedicated to providing continuity of care and remote care, with emphasis on prevention and close monitoring of patients through our Telemonitoring service, who are accompanied and guided, 24 hours a day, by a team of highly trained professionals in their work areas. Our business model adapts to the specific needs of each institution, becoming an ally and strategic complement for doctors, insurers and health providers, delivering an innovative service with high added value and focused … Type: | 0 | 0 | 0 | 14 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 19 |
 | AC Immune We shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical … Type: | 4 | 1 | 2 | 171 |
 | ACOBIOM Biomarkers & Diagnostics for Precision Medicine Acobiom is specialized in the identification of new Biomarkers and in the development of innovative Diagnostics in Translational Research and Precision Medicine. The company provides also customized services in genomics, transcriptomics, bioinformatics and biostatistics (data science), thanks to its technology platform and its scientific expertise. For more information about Acobiom, please contact the company by email: busdev@acobiom.com, or visit its website: www.acobiom.com. Biomarker, Diagnostics, Companion diagnostics, Bioinformatics, Alzheimer, Pancreatic cancer, Precision medicine, Personalized medicine, biostatistics, artificial intelligence, biomarkers, targeted therapy, cancer, data science, breast cancer, and lung cancer Type: | 2 | 2 | 1 | 7 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 0 | 0 | 0 | 5 |
 | ACS Biotech [Automatic translation follows] The cartilage repair solution ACS Biotech Develops Innovative, Reliable, Durable Injectable Cartilage Repair Solution to Treat Cartilage Injuries Type: | 13 | 5 | 7 | 7 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 37 |
 | Activatec Ltd Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, … Type: | 2 | 0 | 1 | 1 |
 | ACTIV'INSIDE Science Inside, Claims Outside ACTIV'INSIDE: Science inside, Claims outside ACTIV'INSIDE is a French foodtech company specialized in the development, production and marketing of nutraceuticals, from natural active ingredients and botanical extracts, to contract manufacturing and private labelling services for the health nutrition industry. ACTIV'INSIDE develops innovative active solutions, available as ingredient or as ready-to use formulation for private labelling, supported by scientifically proven efficacy, clinical studies and proprietary validated claims. Each formulation combines bioavailable ingredients with complementary mechanisms of action. ACTIV'INSIDE also offers a full range of standardized premium botanical extracts, with a strong expertise in grape and saffron. Since … Type: | 8 | 4 | 7 | 59 |
 | ACTO Field Force Effectiveness in Biopharma ACTO is the #1 learning and insights platform for the Life Sciences industry, purpose-built to help drive commercial excellence. Optimized for product launches, new hire onboarding, and sales meetings, ACTO helps Sales, Marketing, and Commercial Learning & Development leaders reduce ramp time for field reps and impact performance. Sales Training, Commercialization, Life Sciences, Sales Enablement, Pharmaceuticals, Medical Devices, Product Launch, Biopharma Sales, and Field Force Effectiveness Type: | 6 | 1 | 6 | 90 |
 | Adan Medical Innovation Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a … Type: | 0 | 0 | 0 | 8 |
 | Adaptive Biotechnologies Corp. Every immune system has a story to tell; the key is knowing how to listen. Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated. For more information, please … Type: | 5 | 1 | 5 | 715 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 0 | 0 | 0 | 42 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team … Type: | 1 | 0 | 1 | 301 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 2 | 0 | 2 | 25 |
 | Addgene A Better Way to Share Science Addgene is a nonprofit plasmid repository located in Watertown, Massachusetts. Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Addgene’s repository contains over 70,000 plasmids, including special collections on CRISPR, fluorescent proteins, chemogenetics, optogenetics, and viral plasmids. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. There is no cost for scientists to deposit … Type: | 2 | 0 | 0 | 120 |
 | Addicted2Success This Website Will Change Your Life Our mission at Addicted2Success is to empower and inspire people by spreading knowledge of self development and life changing stories to the world. We show you what it really takes to become a successful human being. With new motivational videos, interviews, audio and more with your favourite entrepreneurs, life coaches, celebrities and inspirational people from all over the world. Type: | 0 | 0 | 0 | 26 |
 | Ademtech [Automatic translation follows] Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), very magnetic (iron oxide content>70%), calibrated from 100 to 500 nm (+ /- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, viruses) … Type: | 0 | 0 | 0 | 28 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 3 | 2 | 3 | 116 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 9 | 3 | 6 | 64 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | adMare BioInnovations Building Canada's life sciences industry from sea to sea With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability. www.admarebio.com Avec des bureaux situés à Montréal, Vancouver … Type: | 5 | 1 | 4 | 138 |
 | ADOCIA "Innovative medicine for everyone, everywhere" "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, … Type: | 4 | 2 | 2 | 86 |
 | ADOR Diagnostics Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included … Type: | 0 | 0 | 0 | 23 |
 | Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: | 0 | 0 | 0 | 3 |
 | Advanced Accelerator Applications We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine. Type: | 4 | 2 | 1 | 925 |
 | Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: | 4 | 1 | 3 | 22 |
 | Advanced Brain Monitoring Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals. Type: | 1 | 0 | 1 | 43 |
 | Advanced Instruments, LLC Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for … Type: | 2 | 0 | 1 | 469 |
 | Advancells Stem Cell Research & Development in India. Advancells offers stem cells for various chronic conditions and lifestyle disorders. Stem Cell Processing Laboratory , stem cells, and stem cells provider Type: | 0 | 0 | 0 | 25 |
 | Advantis Medical Imaging A pioneering manufacturer of cloud-based medical imaging software solutions. Advantis Medical Imaging is a pioneering manufacturer of cloud-based medical imaging software solutions. The company is on a mission to make medical image analysis more quantitative, accessible and automated through AI and cloud technology. Our flagship product, Brainance MD is a FDA cleared and CE Marked advanced neuroimaging platform intended to be used for the display and processing of multiple brain MRI sequences in a unified and highly intuitive user web-interface. The fully DICOM compliant application is provided as a Software as a Service (SaaS) and offers analysis and visualization capabilities … Type: | 0 | 0 | 0 | 14 |
 | ADVANZ PHARMA Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more … Type: | 1 | 0 | 1 | 630 |
 | Advesya Science that defies cancer Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune Type: | 6 | 2 | 1 | 23 |
 | Advicenne Pathbreaking treatment for rare diseases. Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. Advicenne have spent more than 10 years developing products for the treatment of rare renal diseases. At Advicenne, we are committed to developing and commercializing medicines that are suitable for both children and adults – groundbreaking treatments for rare diseases should be available to patients of all ages. Laboratoire Pharmaceutique | 0 | 0 | 0 | 28 |
 | ADx NeuroSciences Mind your brain! ADx NeuroSciences develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. Both in vitro diagnostic companies as well as pharma companies benefit from the ADx technology. IVD companies utilize the ADx biomarkers and antibodies on various automated platforms and test kits. In search of novel therapies, pharmaceutical companies rely on the ADx assays and services to accelerate and improve the design of large clinical trials. ADx was founded in 2011 by 4 pioneers in biomarker … | 0 | 0 | 0 | 24 |
 | AEFI - Asociación Española de Farmacéuticos de la Industria [Automatic translation follows] Non-profit association, which brings together professionals from the pharmaceutical industry sector Established in 1976, the Spanish Association of Industrial Pharmacists is a technical-scientific association that brings together professionals who, from various fields, work in the pharmaceutical industry, institutions or entities linked to the pharmaceutical and health sector (medicines, cosmetics, foods, medicinal plants, health products, etc.). Visit our blog 💻 https://www.aefi.org/blog/ Sign up for our training 📚 https://aefi.org/calendario-formaciones/ Pharmacy, Pharmaceutical Industry, Health Products, Medical Technology, Regulations, Quality, Training, GxP, EMA, Cosmetics, Veterinary, AEMPS, FENIN, Farmaindustria, Pharmatech, Veterindustria, Galénica, FDA, Registries, Work Groups, Employment Exchange, Networking , Symposium, Pharmacovigilance, … Type: | 1 | 0 | 0 | 38 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 27 |
 | Aelius Biotech Your gastrointestinal research partner. Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract. | 0 | 0 | 0 | 11 |
 | AELIX Therapeutics Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen. Type: | 2 | 1 | 1 | 6 |
 | Aenitis Technologies Acoustic Cell Processing Solution Aenitis develops and promotes devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focuses on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation. Sorting, acoustophoresis, medical devices, cells, and Bioproduction Type: | 19 | 3 | 17 | 15 |
 | Aeras Aeras is a non-profit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Netherlands’ Ministry of Foreign Affairs and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. tuberculosis, vaccines, clinical trials, vaccine manufacturing, and HIV Type: | 1 | 0 | 1 | 63 |
 | Aerospec Holistic air pollution analysis to save lives by empowering individuals and governments to create a cleaner globe AeroSpec’s technology measures the chemical composition of air pollution - providing detailed analysis on its source, its makeup, and potential health effects. We provide comprehensive and actionable data that empowers research labs and environmental agencies to improve air quality and global health. High levels of particulate matter (PM) is associated with 7 million premature deaths worldwide and additional health effects. 84% of the global population is currently exposed to levels higher than recommended limits. Controlling air pollution requires informative monitoring, but understanding the … Type: | 2 | 1 | 1 | 8 |
 | AESEG [Automatic translation follows] We are the association of the pharmaceutical industry of generic medicines in Spain. AESEG is the association of the pharmaceutical industry of generic medicines in Spain and the qualified business interlocutor in this matter. All pharmaceutical specialty laboratories, pharmaceutical raw material and active ingredient manufacturing companies, or technological development companies whose main activity is carried out in the field of generics within the national territory can be members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization to promote the knowledge and use of generic medicines, creating a true generic … Type: | 0 | 0 | 0 | 11 |
 | Aether We're building the post-scarcity future. Aether’s mission is to build a future of abundance for the human race. We believe that the machinery of nature can be reverse engineered to manufacture any arrangement of atoms desired, enabling the production of new products anywhere on earth. Type: | 0 | 0 | 0 | 39 |
 | AFCROs Les entreprises de la Recherche Clinique 🇫🇷 The French Association of CROs (Association Française des CROs or “AFCROs”) was established in 2002 in order to represent clinical and epidemiological research organizations, headquartered or operating in France, that provide services to the pharmaceutical and medical device sectors. Its purpose is to maintain a dialogue with French health authorities and institutions, patient associations and the industry and at a European level with EUCROF on the role of CROs within the context of clinical development of healthcare products. Essais cliniques, Pharmaco-épidémiologie, Etudes Observationnelles, Données de santé en vie réelle, Economie de la Santé, … Type: | 17 | 4 | 13 | 7 |
 | AFFICHEM [Automatic translation follows] Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: | 0 | 0 | 0 | 1 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 3 | 3 | 1 | 36 |
 | AFFiRiS AG Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you. We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and … Type: | 0 | 0 | 0 | 5 |
 | AFFIRMA BIOTECH SL Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation. Type: | 0 | 0 | 0 | 5 |
 | AfricaBio AfricaBio is an independent, non-profit biotechnology stakeholders association. Its key role is to provide accurate information and create awareness, understanding as well as knowledge on biotechnology and biosafety in South Africa and the African region. | 3 | 1 | 2 | 17 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 70 | 21 | 54 | 107 |
 | AgBoost Data has a story to tell, we give it a voice. Agric-Bioformatics, INC is a technology company designed for the livestock industry. Our goal is to analyze, manage and improve performance and genomics data. Our cloud based Platform AgBoostTM will process and streamline data for selective breeding, health, market value and nutrition management. We aim to provide livestock producers an affordable, easy-to- use tool that allows for better access to, and understanding of, genomic information. Agric- Bioformatics will revolutionize the industry by determining market value of herd from an early age; providing for better breeding, enhanced nutrition management, and organization … Type: | 0 | 0 | 0 | 5 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 5 |
 | AgenT Detect Alzheimer's earlier, when it could be prevented AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. ALzheimer's disease, Biotechnology, Diagnosis, Machine learning, and AI Type: | 10 | 2 | 6 | 33 |
 | Agenus Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing Type: | 1 | 0 | 1 | 297 |
 | AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: | 0 | 0 | 0 | 12 |
 | AgGene Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology Type: | 2 | 2 | 0 | 5 |
 | Agilent Technologies Let’s Bring Great Science to Life. Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s … Type: | 15 | 2 | 0 | 17,329 |
 | Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: | 2 | 1 | 1 | 505 |
 | Aglaé [Automatic translation follows] The pioneering company in luminescent plants! Event services, design of interior and landscaped spaces. We design scenographic installations for companies thanks to the magic of glowing plants. plant design, events, plant research, biology, scenography, innovation, floral decoration, interior decoration, landscaping, smartcity, biotechnology, start-up, Paris, Ile-de-France, agency, conception, light, design, urban planning, luminescent plant, green, and communication Type: | 20 | 8 | 15 | 32 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: | 0 | 0 | 0 | 49 |
Startup